Sort
15,440 grants matching “organoids”
Regulation of Tight Junction Molecular Composition by Na/K-ATPase
$191,459Isabel Maria Perez · Marshall University · P20 · FY2019 · GM
Diapause-like adaptation of triple-negative breast cancer cells during chemotherapy treatment
$191,280Eugen Dhimolea · Albert Einstein College Of Medicine · R21 · FY2023 · CA
Application of in vivo humanized PDX mouse model and ex vivo organoid model to assess the therapeutic efficacy of combinatorial therapy for pseudomyxoma peritonei
$191,278Yong J Lee · Cedars-Sinai Medical Center · R21 · FY2023 · CA
Rational Design of Oral Drugs Targeting Mucosa Delivery
$191,250Qun Wang · Iowa State University · R21 · FY2023 · EB
Rational Design of Oral Drugs Targeting Mucosa Delivery
$191,250Qun Wang · Iowa State University · R21 · FY2024 · EB
Administrative Core
$191,077Collin M Blakely · University Of California, San Francisco · U54 · FY2025 · CA
Investigating the biology and therapeutic vulnerabilities of ER+ metastatic breast cancer with activating HER2 mutations
$191,014Utthara Nayar · Johns Hopkins University · K22 · FY2022 · CA
B cell dynamics and immune memory formation in human vaccination
$190,944David Richard Glass · Fred Hutchinson Cancer Center · K99 · FY2025 · AI
Mechanisms of epigenetic regulation of estrogen receptor function in breast cancer
$190,864Eneda Toska · Johns Hopkins University · K22 · FY2022 · CA
Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
$190,822Teresa K Woodruff · Northwestern University At Chicago · UH3 · FY2015 · TR
Using human intestinal organoids to evaluate JCV fecal/oral transmission
$190,625Megan L Gasparovic · University Of Florida · R21 · FY2025 · AI
Mechanisms of epilepsy in human neurodevelopmental disorders: focus on Phelan-McDermid Syndrome
$190,625Oleksandr Shcheglovitov · University Of Utah · R21 · FY2019 · NS
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
$190,500Chengyu Liang · University Of Southern California · R01 · FY2020 · CA
Investigation of Neural Pathogenic Mechanisms Associated with Congenital Disorders of Glycosylation
$190,473Akhilesh Pandey · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · NS
Biospecimens and Patient Registry
$190,434Gary L Keeney · Mayo Clinic Rochester · P50 · FY2021 · CA
Vascularized cell-based device for restoring physiological homeostasis
$190,398Nolan Lee Boyd · University Of Louisville · R21 · FY2017 · EB
Clinical Translation Core
$190,000Scott H Donaldson · Univ Of North Carolina Chapel Hill · P30 · FY2015 · DK
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
$190,000Jorge A. Piedrahita · North Carolina State University Raleigh · R21 · FY2023 · OD
Cell Models Core
$190,000Scott H Randell · Univ Of North Carolina Chapel Hill · P30 · FY2015 · DK
Pre-Clinical Core
$190,000Martina Gentzsch · Univ Of North Carolina Chapel Hill · P30 · FY2015 · DK
Exploring a new model to study developmental eye diseases
$190,000Elena V Semina · Medical College Of Wisconsin · R21 · FY2024 · EY
Drug susceptibilities in fusion oncogene-driven pediatric sarcomas
$189,986Irwin H. Gelman · Roswell Park Cancer Institute Corp · R21 · FY2020 · CA
Core 3: Histology and Tissue Core
$189,862Sarah P Thayer · University Of Nebraska Medical Center · P01 · FY2020 · CA
Core 3: Histology and Tissue Core
$189,862Sarah P Thayer · University Of Nebraska Medical Center · P01 · FY2021 · CA
Core 1: Biospecimen and Pathology Core (BiPC)
$189,829Fausto Rodriguez · University Of California Los Angeles · P50 · FY2022 · CA